These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 38262978)

  • 1. Incidence, risk factors and maternal outcomes of unsuspected placenta accreta spectrum disorders: a retrospective cohort study.
    Zhao J; Li Q; Liao E; Shi H; Luo X; Zhang L; Qi H; Zhang H; Li J
    BMC Pregnancy Childbirth; 2024 Jan; 24(1):76. PubMed ID: 38262978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between Number of Prior Cesareans and Early Preterm Delivery in Women with Abnormal Placentation.
    Oben A; Ausbeck EB; Gazi MN; Subramaniam A; Harper LM; Szychowski JM; Tita AT
    Am J Perinatol; 2021 Mar; 38(4):326-331. PubMed ID: 32992353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unsuspected placenta accreta spectrum at vaginal delivery: assessment of incidence, characteristics, and maternal morbidity.
    Rau AR; Youssefzadeh AC; Matsuzaki S; Mandelbaum RS; Ouzounian JG; Matsuo K
    Am J Obstet Gynecol MFM; 2023 May; 5(5):100805. PubMed ID: 36774226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Focal-occult placenta accreta: a clandestine source of maternal morbidity.
    Larish A; Horst K; Brunton J; Schenone M; Branda M; Mehta R; Packard A; VanBuren W; Norgan A; Shahi M; Missert A; Pompeian R; Greenwood J; Theiler R
    Am J Obstet Gynecol MFM; 2023 Jun; 5(6):100924. PubMed ID: 36934974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maternal outcomes in unexpected placenta accreta spectrum disorders: single-center experience with a multidisciplinary team.
    Erfani H; Fox KA; Clark SL; Rac M; Rocky Hui SK; Rezaei A; Aalipour S; Shamshirsaz AA; Nassr AA; Salmanian B; Stewart KA; Kravitz ES; Eppes C; Coburn M; Espinoza J; Teruya J; Belfort MA; Shamshirsaz AA
    Am J Obstet Gynecol; 2019 Oct; 221(4):337.e1-337.e5. PubMed ID: 31173748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Risk factor assessment and adverse outcome prediction of placenta accreta in pregnant women after cesarean section complicated with placenta previa: a national multicenter retrospective study].
    Bai GQ; Chen WL; Huang XH; Zhao SJ; Zhao SP; Chen XJ; Chen SW; Yang H; Lu X; Liu GY; Chen QH; Zhang LA; Jin L
    Zhonghua Fu Chan Ke Za Zhi; 2023 Jan; 58(1):26-36. PubMed ID: 36720612
    [No Abstract]   [Full Text] [Related]  

  • 7. Association of Placenta Previa With Severe Maternal Morbidity Among Patients With Placenta Accreta Spectrum Disorder.
    Han X; Guo Z; Yang X; Yang H; Ma J
    JAMA Netw Open; 2022 Aug; 5(8):e2228002. PubMed ID: 35994286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for placenta accreta spectrum: findings from the Japan environment and Children's study.
    Kyozuka H; Yamaguchi A; Suzuki D; Fujimori K; Hosoya M; Yasumura S; Yokoyama T; Sato A; Hashimoto K;
    BMC Pregnancy Childbirth; 2019 Nov; 19(1):447. PubMed ID: 31775687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of placenta previa attached to cesarean scar for adverse pregnant outcomes in patients with placenta accreta spectrum disorders].
    Zheng WR; Yang XR; Sun J; Mu Y; Yan J; Yang HX
    Zhonghua Fu Chan Ke Za Zhi; 2021 Dec; 56(12):861-867. PubMed ID: 34954965
    [No Abstract]   [Full Text] [Related]  

  • 10. Placenta Accreta Spectrum Without Placenta Previa.
    Carusi DA; Fox KA; Lyell DJ; Perlman NC; Aalipour S; Einerson BD; Belfort MA; Silver RM; Shamshirsaz AA
    Obstet Gynecol; 2020 Sep; 136(3):458-465. PubMed ID: 32769646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of emergency Cesarean delivery in pregnancies complicated by placenta previa with or without placenta accreta spectrum disorder: analysis of ADoPAD cohort.
    ADoPAD (Antenatal Diagnosis of Placental Attachment Disorders) Study Group
    Ultrasound Obstet Gynecol; 2024 Feb; 63(2):243-250. PubMed ID: 37698306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of placenta accreta spectrum at vaginal birth after cesarean delivery.
    Matsuzaki S; Rau AR; Mandelbaum RS; Tavakoli A; Mazza GR; Ouzounian JG; Matsuo K
    Am J Obstet Gynecol MFM; 2023 Oct; 5(10):101115. PubMed ID: 37543142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of previous placenta previa on outcome of next pregnancy: a 10-year retrospective cohort study.
    Zhang L; Bi S; Du L; Gong J; Chen J; Sun W; Shen X; Tang J; Ren L; Chai G; Wang Z; Chen D
    BMC Pregnancy Childbirth; 2020 Apr; 20(1):212. PubMed ID: 32293318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics and outcomes of pregnant women with placenta accreta spectrum in Italy: A prospective population-based cohort study.
    Ornaghi S; Maraschini A; Donati S;
    PLoS One; 2021; 16(6):e0252654. PubMed ID: 34086797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemorrhagic morbidity in placenta accreta spectrum with and without placenta previa.
    Mulla BM; Weatherford R; Redhunt AM; Modest AM; Hacker MR; Hecht JL; Spiel MH; Shainker SA
    Arch Gynecol Obstet; 2019 Dec; 300(6):1601-1606. PubMed ID: 31691015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro fertilization as an independent risk factor for placenta accreta spectrum.
    Salmanian B; Fox KA; Arian SE; Erfani H; Clark SL; Aagaard KM; Detlefs SE; Aalipour S; Espinoza J; Nassr AA; Gibbons WE; Shamshirsaz AA; Belfort MA; Shamshirsaz AA
    Am J Obstet Gynecol; 2020 Oct; 223(4):568.e1-568.e5. PubMed ID: 32360847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors and clinical outcomes for placenta accreta spectrum with or without placenta previa.
    Ogawa K; Jwa SC; Morisaki N; Sago H
    Arch Gynecol Obstet; 2022 Mar; 305(3):607-615. PubMed ID: 34448037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Placenta Accreta Spectrum (PAS) disorders: incidence, risk factors and outcomes of different management strategies in a tertiary referral hospital in Minia, Egypt: a prospective study.
    El Gelany S; Mosbeh MH; Ibrahim EM; Mohammed M; Khalifa EM; Abdelhakium AK; Yousef AM; Hassan H; Goma K; Alghany AA; Mohammed HF; Azmy AM; Ali WA; Abdelraheim AR
    BMC Pregnancy Childbirth; 2019 Aug; 19(1):313. PubMed ID: 31455286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between short inter-pregnancy interval and placenta previa and placenta accreta spectrum with respect to maternal age at first cesarean delivery.
    Liang Y; Zhang L; Huang L; Li Y; Chen J; Bi S; Huang M; Tan H; Lai S; Liang J; Gu S; Jia J; Wen S; Wang Z; Cao Y; Wang S; Xu X; Feng L; Zhao X; Zhao Y; Zhu Q; Qi H; Zhang L; Li H; Du L; Chen D
    J Matern Fetal Neonatal Med; 2023 Dec; 36(1):2192853. PubMed ID: 36966813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of contingent screening for placenta accreta spectrum disorders based on persistent low-lying placenta and previous uterine surgery.
    Coutinho CM; Giorgione V; Noel L; Liu B; Chandraharan E; Pryce J; Frick AP; Thilaganathan B; Bhide A
    Ultrasound Obstet Gynecol; 2021 Jan; 57(1):91-96. PubMed ID: 32865834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.